drugset
drugset / Trial / NCT03778320

A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers

NCT03778320 ↗

Phase 1 Completed 13 enrolled Concert Pharmaceuticals
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study will assess the safety, tolerability and pharmacokinetic (PK) profile of CTP-692 vs D serine.

Timeline

Start
2018-12-14
Primary completion
2018-12-23
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP-692 Unknown — Oral
Comparator D-serine Unknown — Oral

Indications

No indication recorded.